| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Hull Andrew serves as a Director at INM. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $61K at current prices.
The biggest single holding is INM (~$61K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 37,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | INM Inmed Pharmaceuticals Inc. | Director | Buy | 37,500 | $0.39 | $14,625.00 | +4,947% | -18.4% | -58.0% |